GMP non-compliance can spill over and impact patient access to life-saving medications.
Sharon Ayd
Advertisement
Sharon Ayd is chief scientific officer and SVP, Pharmaceuticals at Regulatory Compliance Associates.
Articles by Sharon Ayd
Creating a quality culture can prevent the costs and challenges associated with receiving a consent decree.
Advertisement
Latest Updated Articles
Managing the Cost of Non-ComplianceNovember 2nd 2017
Impact of Non-Compliance on the American Healthcare ConsumerDecember 2nd 2018
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
USP Reports Drug Discontinuations on the Rise
3
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
4
Investigating Patient Complaints About Combination Products
5